Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells

• US 7,153,685 B2
• Filed: 03/11/2002
• Issued: 12/26/2006
• Est. Priority Date: 03/11/2002
• Status: Active Grant

• Current Assignee: Board of Trustees of The University of Illinois
• Original Assignee: Board of Trustees of The University of Illinois
• Inventors: Shapiro, David J., Mao, Chengjian
• Primary Examiner(s): EPPS -SMITH, JANET L
• Application Number:
  US10/095,373
• Publication Number:
  US 20030199022A1
• Time in Patent Office: 1,751 Days
• Field of Search: 536/23.1, 536/24.1, 435/320.1, 435/69.1, 435/325, 435/455, 514/44
• US Class Current: 435/325
• CPC Class Codes: A01K 2217/05 Animals comprising random inserted nucleic acids (transgenic)
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: C07K 14/721 Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
• CPC Class Codes: C07K 2319/00 Fusion polypeptide

Abstract

Novel tamoxifen inducible and ICI 182,780 repressible expression systems comprising mutant estrogen receptors and mutant estrogen response element are disclosed. Such systems have a wide variety of applications, including gene therapy and in vivo and in vitro expression, as well as their use in transgenic animals.

Claims

1. An isolated polynucleotide, comprising:

a first polynucleotide; and

a second polynucleotide operably linked to the first polynucleotide;

wherein when the first polynucleotide is inserted into a promoter region of a gene, enhances transcription of the gene, when the first polynucleotide is bound by a mutant estrogen receptor to which is bound 4-hydroxytamoxifen,

the first polynucleotide comprises nucleotides 2–

6 and 10–

14 of SEQ ID NO;

75, and

the mutant estrogen receptor has the amino acid sequence of SEQ ID NO;

4.

2. The polynucleotide of claim 1, wherein the first polynucleotide comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOS:

75, 78, 80 and 82.

3. A vector, comprising the polynucleotide of claim 2.

4. An isolated or cultured cell, comprising the polynucleotide of claim 2.

5. The polynucleotide of claim 1, wherein the second polynucleotide comprises a nucleic acid sequence encoding a polypeptide selected from the group consisting of SEQ ID NOS:

4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 66, 68, 70 and 72.

6. The polynucleotide of claim 5, wherein the first polynucleotide comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOS:

75, 78, 80 and 82.

7. A vector, comprising the polynucleotide of claim 6.

8. An isolated or cultured cell, comprising the polynucleotide of claim 6.

9. A vector, comprising the polynucleotide of claim 5.

10. An isolated or cultured cell, comprising the polynucleotide of claim 5.

11. The polynucleotide of claim 1, wherein the second polynucleotide encodes a therapeutic polypeptide or an antibody.

12. A vector, comprising the polynucleotide of claim 11.

13. An isolated or cultured cell, comprising the polynucleotide of claim 11.

14. The polynucleotide of claim 11, wherein the first polynucleotide comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOS:

75, 78, 80 and 82.

15. A vector, comprising the polynucleotide of claim 14.

16. An isolated or cultured cell, comprising the polynucleotide of claim 14.

17. The polynucleotide of claim 11, wherein the second polynucleotide comprises a nucleic acid sequence encoding a polypeptide selected from the group consisting of SEQ ID NOS:

4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 66, 68, 70 and 72.

18. A vector, comprising the polynucleotide of claim 17.

19. An isolated or cultured cell, comprising the polynucleotide of claim 17.

20. The polynucleotide of claim 1, wherein the second polynucleotide is an antisense polynucleotide.

21. A vector, comprising the polynucleotide of claim 20.

22. An isolated or cultured cell, comprising the polynucleotide of claim 20.

23. The polynucleotide of claim 20, wherein the first polynucleotide comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOS:

75, 78, 80 and 82.

24. A vector, comprising the polynucleotide of claim 23.

25. An isolated or cultured cell, comprising the polynucleotide of claim 23.

26. The polynucleotide of claim 20, wherein the second polynucleotide comprises a nucleic acid sequence encoding a polypeptide selected from the group consisting of SEQ ID NOS:

4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 66, 68, 70 and 72.

27. A vector, comprising the polynucleotide of claim 26.

28. An isolated or cultured cell, comprising the polynucleotide of claim 26.

29. A vector, comprising the polynucleotide of claim 1.

30. An isolated or cultured cell, comprising the polynucleotide of claim 1.